Hepatitis C hos børn

Vibeke Brix Christensen; Sannie Brit Nordly; Bjørn Fischler; Mette Skalshøi Kjær; Marianne Hørby Jørgensen

Hepatitis C hos børn

Vibeke Brix Christensen, Sannie Brit Nordly, Bjørn Fischler, Mette Skalshøi Kjær, Marianne Hørby Jørgensen

Abstract

Chronic hepatitis C (HCV) infection has a prevalence of 2-3% worldwide. The vertical transmission rate is approximately 5%. There is no evidence to recommend abstinence from breastfeeding or elective C-section to prevent transmission. In children, the natural history of HCV infection is typically benign, but liver cirrhosis and hepatocellulary carcinoma are later complications. Children with HCV infection may benefit from early treatment with pegylated interferon and ribavirin with duration depending on genotype. Overall, response to antiviral treatment of HCV infected children is comparable to results in adults.

Bidragets oversatte titel	Hepatitis C infection in children.
Originalsprog	Dansk
Artikelnummer	V02130136
Tidsskrift	Ugeskrift for Laeger
Vol/bind	176
Udgave nummer	8
Sider (fra-til)	722-725
Antal sider	4
ISSN	0041-5782
Status	Udgivet - 14 apr. 2014

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Citationsformater

@article{c16a69534d624cecab550fcbb4a46a85,

title = "Hepatitis C hos b{\o}rn",

abstract = "Chronic hepatitis C (HCV) infection has a prevalence of 2-3% worldwide. The vertical transmission rate is approximately 5%. There is no evidence to recommend abstinence from breastfeeding or elective C-section to prevent transmission. In children, the natural history of HCV infection is typically benign, but liver cirrhosis and hepatocellulary carcinoma are later complications. Children with HCV infection may benefit from early treatment with pegylated interferon and ribavirin with duration depending on genotype. Overall, response to antiviral treatment of HCV infected children is comparable to results in adults.",

author = "Christensen, {Vibeke Brix} and Nordly, {Sannie Brit} and Bj{\o}rn Fischler and Kj{\ae}r, {Mette Skalsh{\o}i} and J{\o}rgensen, {Marianne H{\o}rby}",

year = "2014",

month = apr,

day = "14",

language = "Dansk",

volume = "176",

pages = "722--725",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "8",

}

TY - JOUR

T1 - Hepatitis C hos børn

AU - Christensen, Vibeke Brix

AU - Nordly, Sannie Brit

AU - Fischler, Bjørn

AU - Kjær, Mette Skalshøi

AU - Jørgensen, Marianne Hørby

PY - 2014/4/14

Y1 - 2014/4/14

N2 - Chronic hepatitis C (HCV) infection has a prevalence of 2-3% worldwide. The vertical transmission rate is approximately 5%. There is no evidence to recommend abstinence from breastfeeding or elective C-section to prevent transmission. In children, the natural history of HCV infection is typically benign, but liver cirrhosis and hepatocellulary carcinoma are later complications. Children with HCV infection may benefit from early treatment with pegylated interferon and ribavirin with duration depending on genotype. Overall, response to antiviral treatment of HCV infected children is comparable to results in adults.

AB - Chronic hepatitis C (HCV) infection has a prevalence of 2-3% worldwide. The vertical transmission rate is approximately 5%. There is no evidence to recommend abstinence from breastfeeding or elective C-section to prevent transmission. In children, the natural history of HCV infection is typically benign, but liver cirrhosis and hepatocellulary carcinoma are later complications. Children with HCV infection may benefit from early treatment with pegylated interferon and ribavirin with duration depending on genotype. Overall, response to antiviral treatment of HCV infected children is comparable to results in adults.

M3 - Tidsskriftartikel

C2 - 25096460

SN - 0041-5782

VL - 176

SP - 722

EP - 725

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 8

M1 - V02130136

ER -

Hepatitis C hos børn

Abstract

FN’s Verdensmål

Fingeraftryk

Citationsformater